MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Frontotemporal dementias: Clinical features"

  • 2017 International Congress

    The Corticobasal Degeneration Functional Rating Scale (CBD-FS)

    A. Lang, G. Stebbins, A. Boxer (Toronto, Canada)

    Objective: To develop a patient/care giver-reported scale that is capable of assessing functional disability in CBD that can be easily and reliably used in clinical…
  • 2016 International Congress

    Prevalence and incidence of PSP and CBS: A new prospective study in the UK

    J.B. Rowe, I.T. Coyle-Gilchrist (Cambridge, United Kingdom)

    Objective: To estimate the prevalence and incidence of progressive supranuclear palsy (PSP, 'Richardson's syndrome') and corticobasal syndromes (CBS); in the context of all clinical phenotypes…
  • 2016 International Congress

    Allele specificity in neurodegenerative olfactory dysfunction

    B.A. Chase, K. Markopoulou, P. Robowski, A. Strongosky, E. Narozanska, E.J. Sitek, M. Berdynski, M. Barcikowska, M.C. Baker, R. Radamakers, J. Slawek, Z.K. Wszolek (Omaha, NE, USA)

    Objective: Assess olfactory dysfunction in carriers of the p.N279K and p.P301L MAPT mutations, which cause FTDP-17, to understand how genotypic differences contribute to the severity…
  • 2016 International Congress

    Social cognition assessment in progressive supranuclear palsy: The cognitive interface with frontotemporal dementia

    E.P.F. Resende, P. Caramelli, F.E.C. Cardoso, H.C. Guimarães, M. Hornberger, M. Bertoux, A.L. Teixeira, L. Cruz de Souza (Belo Horizonte, Brazil)

    Objective: To explore the cognitive profile of PSP patients in tests of social cognition and to compare their performance to patients with behavioural variant frontotemporal…
  • 2016 International Congress

    A heterozygous splicing mutation c.823-10G>T at the intron9/exon 10 of the MAPT gene in an Irish family with FTDP- 17

    E.M. Fallon, D.A. Olszewska, C. McGuigan, I. Delon, F. Brett, B. Lawlor, M. Hutchinson, M. Hutton, T. Lynch (Dublin, Ireland)

    Objective: *Authors EMF and DAO contributed equally. To describe the phenotype of the second reported pedigree with the heterozygous splicing mutation c.823-10G>T at the intron…
  • « Previous Page
  • 1
  • 2

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Safety and Tolerability of a Ketone Supplement in Parkinson's Disease
  • Successful external defibrillation in a patient with bilateral deep brain stimulation
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley